Revelle Aesthetics Unveils New Minimally Invasive Procedure for Cellulite Reduction at Premier Aesthetic Plastic Surgery Conference
The Company recently introduced Avli an innovative FDA-cleared device that reduces the appearance of cellulite on the buttocks and thighs temporarily* in a one-time procedure at The Aesthetic Societys annual plastic surgery conference.
- The Company recently introduced Avli an innovative FDA-cleared device that reduces the appearance of cellulite on the buttocks and thighs temporarily* in a one-time procedure at The Aesthetic Societys annual plastic surgery conference.
- Revelle was born out of ExploraMed, a Silicon Valley incubator known for engineering unique innovations in challenging-to-solve-for therapeutic areas, shared Caroline Van Hove, President and CEO of Revelle Aesthetics.
- Avli is a one-time-use disposable device for cellulite designed to be used in a single in-office procedure using a Targeted, Verifiable Subcision method.
- The company plans a targeted rollout to cellulite and body treatment experts in the fields of plastic surgery and dermatology.